Lyndra Therapeutics, Inc.

formerly LyndraClosed

What if we stopped trying to change the patient and changed the pill instead?

Lyndra Therapeutics, Inc. is a biotech company in Watertown, United States, founded in 2016. It has raised $329.8M across 6 rounds, most recently a $101.0M Series E in December 2023.

Employees
51–200
Founded
2016
Business Model
B2B
Website
lyndra.com
Total Funding
$329.8M
Last Round
$101.0M Series EDec 2023
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds and 8 investors for this company. to use credits for reveals, or explore the API.

About

Lyndra Therapeutics was a clinical-stage biopharmaceutical company dedicated to developing long-acting oral therapies using its proprietary LYNX platform. Founded from technology developed at MIT, the platform enables a single pill to deliver medication over a week or longer, improving patient adherence across therapeutic areas including HIV, psychiatry, and contraception. The company ceased operations in March 2025 after raising over $380M.

Funding History

Data from Indexed.vcUpdated
Series ESeries EDec 2023
$101.0M

5 more events

  • Series D20231 investor
  • Series C20215 investors
  • Series B20193 investors

Funding: Series A through Series E. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×2
  • Backend ×1
  • Cloud/Infrastructure ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Lyndra Therapeutics, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/lyndra-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/lyndra-therapeutics-inc" alt="Lyndra Therapeutics, Inc. on Indexed.vc" width="260" height="76" /></a>